Nabors Industries Ltd. (NBR) Is A Top Stock To Buy According To Bill Miller
Nabors Industries Ltd. (NBR) Is A Top Stock To Buy According To Bill Miller Source: yahoo-finance Country: United States
United States
Corporate earnings, M&A, IPOs, and business developments from the United States.
Crescent Energy Company (CRGY) Is A Top Stock In Miller Value Partners’ Filings
Crescent Energy Company (CRGY) Is A Top Stock In Miller Value Partners’ Filings Source: yahoo-finance Country: United States
Gray Media, Inc. (GTN) Is A Top Stock To Buy According To Miller Value Partners
Gray Media, Inc. (GTN) Is A Top Stock To Buy According To Miller Value Partners Source: yahoo-finance Country: United States
Dow Jones Futures Loom Amid New U.S.-Iran Attacks; Nvidia, Micron, Sandisk Near Buy Points
Dow Jones Futures Loom Amid New U.S.-Iran Attacks; Nvidia, Micron, Sandisk Near Buy Points Source: yahoo-finance Country: United States
The Market Is Missing SanDisk’s Biggest Transformation
The Market Is Missing SanDisk’s Biggest Transformation Source: seekingalpha Country: United States
For Palantir To Justify Its Current Share Price, It Would Need To Increase Revenue To $42 Billion By 2030
For Palantir To Justify Its Current Share Price, It Would Need To Increase Revenue To $42 Billion By 2030 Source: seekingalpha Country: United States
Nvidia signals broadening AI demand, keeps next-generation roadmap unchanged
Nvidia signals broadening AI demand, keeps next-generation roadmap unchanged Source: investing Country: United States
Micron: The Mirage Of A Single-Digit P/E Ratio
Micron: The Mirage Of A Single-Digit P/E Ratio Source: seekingalpha Country: United States
Goldman Sachs flags Fed rate outlook as key risk for U.S. stocks ahead of CPI
Goldman Sachs flags Fed rate outlook as key risk for U.S. stocks ahead of CPI Source: investing Country: United States
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
COPENHAGEN, Denmark, July 12, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1. Source: globenewswire Country: United States